Importer of Controlled Substances Application: Cambridge Isotope Laboratories, 55493 [2020-19806]
Download as PDF
55493
jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 85, No. 174 / Tuesday, September 8, 2020 / Notices
Act of 1930, as amended, 19 U.S.C.
1337, and in section 210.10 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.10 (2020).
Scope of Investigation: Having
considered the complaint, the U.S.
International Trade Commission, on
September 1, 2020, ordered that—
(1) Pursuant to subsection (b) of
section 337 of the Tariff Act of 1930, as
amended, an investigation be instituted
to determine whether there is a
violation of subsection (a)(1)(B) of
section 337 in the importation into the
United States, the sale for importation,
or the sale within the United States after
importation of certain products
identified in paragraph (2) by reason of
infringement of one or more of claims 1,
3, 6, 7, 12, 21–24, 29, 30, and 33–38 of
the ’985 patent and claim 1 of the ’705
patent; and whether an industry in the
United States exists as required by
subsection (a)(2) of section 337;
(2) Pursuant to section 210.10(b)(1) of
the Commission’s Rules of Practice and
Procedure, 19 CFR 210.10(b)(1), the
plain language description of the
accused products or category of accused
products, which defines the scope of the
investigation, is ‘‘variable speed wind
turbine generators having low and zero
voltage ride through capability and
components thereof, namely generators,
power converters, uninterruptible
power supplies, turbine controllers,
blade pitch control systems, and
converter controllers’’;
(3) For the purpose of the
investigation so instituted, the following
are hereby named as parties upon which
this notice of investigation shall be
served:
(a) The complainant is:
General Electric Company, 5 Necco
Street, Boston, MA 02210
(b) The respondents are the following
entities alleged to be in violation of
section 337, and are the parties upon
which the complaint is to be served:
Siemens Gamesa Renewable Energy
Inc., 3500 Quadrangle Boulevard,
Orlando, FL 32817
Siemens Gamesa Renewable Energy A/
S, Borupvej 16, 7330 Brande,
Denmark
Gamesa Electric, S.A.U., Parque
Tecnolo´gico de Bizkaia, Building 206,
48170 Zamudio, BI, Spain
(4) For the investigation so instituted,
the Chief Administrative Law Judge,
U.S. International Trade Commission,
shall designate the presiding
Administrative Law Judge.
The Office of Unfair Import
Investigations will not participate as a
party in this investigation.
VerDate Sep<11>2014
16:32 Sep 04, 2020
Jkt 250001
Responses to the complaint and the
notice of investigation must be
submitted by the named respondents in
accordance with section 210.13 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.13. Pursuant to
19 CFR 201.16(e) and 210.13(a), as
amended in 85 FR 15,798 (Mar. 19,
2020), such responses will be
considered by the Commission if
received not later than 20 days after the
date of service by the complainant of the
complaint and the notice of
investigation. Extensions of time for
submitting responses to the complaint
and the notice of investigation will not
be granted unless good cause therefor is
shown.
Failure of a respondent to file a timely
response to each allegation in the
complaint and in this notice may be
deemed to constitute a waiver of the
right to appear and contest the
allegations of the complaint and this
notice, and to authorize the
administrative law judge and the
Commission, without further notice to
the respondent, to find the facts to be as
alleged in the complaint and this notice
and to enter an initial determination
and a final determination containing
such findings, and may result in the
issuance of an exclusion order or a cease
and desist order or both directed against
the respondent.
By order of the Commission.
Issued: September 1, 2020.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2020–19747 Filed 9–4–20; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–710]
Importer of Controlled Substances
Application: Cambridge Isotope
Laboratories
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
may also file a written request for a
hearing on the application on or before
October 8, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on July 23, 2020,
Cambridge Isotope Laboratories, 50
Frontage Road, Andover, Massachusetts
01810, applied to be registered as an
importer of the following basic class(es)
of controlled substances:
Controlled substance
Gamma Hydroxybutyric
Acid.
Tetrahydrocannabinols ..
Morphine ........................
Drug
code
Schedule
2010
I
7370
9300
I
II
The company plans to import the
listed controlled substances for
analytical research, testing and clinical
trials. No other activity for these drug
codes is authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–19806 Filed 9–4–20; 8:45 am]
BILLING CODE 4410–09–P
Cambridge Isotope
Laboratories has applied to be registered
as an importer of basic class(es) of
controlled substances. Refer to
Supplemental Information listed below
for further drugs information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before October 8, 2020. Such persons
SUMMARY:
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–708]
Bulk Manufacturer of Controlled
Substances Application: Cayman
Chemical Company
Drug Enforcement
Administration, Justice.
AGENCY:
E:\FR\FM\08SEN1.SGM
08SEN1
Agencies
[Federal Register Volume 85, Number 174 (Tuesday, September 8, 2020)]
[Notices]
[Page 55493]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-19806]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-710]
Importer of Controlled Substances Application: Cambridge Isotope
Laboratories
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Cambridge Isotope Laboratories has applied to be registered as
an importer of basic class(es) of controlled substances. Refer to
Supplemental Information listed below for further drugs information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before October 8, 2020.
Such persons may also file a written request for a hearing on the
application on or before October 8, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on July 23, 2020, Cambridge Isotope Laboratories, 50
Frontage Road, Andover, Massachusetts 01810, applied to be registered
as an importer of the following basic class(es) of controlled
substances:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid.............. 2010 I
Tetrahydrocannabinols.................. 7370 I
Morphine............................... 9300 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
analytical research, testing and clinical trials. No other activity for
these drug codes is authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-19806 Filed 9-4-20; 8:45 am]
BILLING CODE 4410-09-P